Record Revenue Growth
MindWalk reported record revenue of $7.6 million for Q1 Fiscal 2026, up 45% year-over-year. Continued operations contributed $3.2 million in revenue, growing 28% year-over-year.
Improved Financial Metrics
Gross profit increased to $4 million with a margin of 53%, and adjusted EBITDA loss was halved to $1.4 million. Operating loss narrowed to $2.7 million, and net loss improved to $3 million.
Strategic Divestiture
The divestiture of Netherlands operations generated $16.1 million in net proceeds, strengthening the balance sheet and allowing concentration on high-margin initiatives.
Successful Rebranding
Transitioned to a unified brand identity under MindWalk, shifting from services to a bio-native AI platform model, and introduced new NASDAQ ticker HYFT.
BioIntelligence Ecosystem
Advanced BioIntelligence ecosystem integrating bio-native AI with over 15 molecules accepted into clinical trials and a 98% success rate in B-cell technology.